- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Harris & Harris Group Reports Financial Statements as of June 30, 2011New York, NY | Posted on August 8th, 2011
As of June 30, 2011, we owned an aggregate of 2,304,149 shares of Solazyme. This position was valued at $44,354,868 as of June 30, 2011, which is included in our total assets of $173,384,222. The key inputs to our valuation of Solazyme were the share price as of the close of trading on June 30, 2011, which was $22.97, less a liquidity discount owing to the lock-up restrictions placed on the shares through an agreement with the underwriters of the IPO. As of August 5, 2011, Solazyme's closing price was $17.61 per share.
About Harris & Harris Group
For more information, please click here
Copyright © Harris & Harris GroupIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
NanoTechnology for Defense (NT4D) October 22nd, 2014
Mechanism behind nature's sparkles revealed October 22nd, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014